JP5525532B2 - 心筋収縮能調整を組み込んだ心臓機能管理 - Google Patents
心筋収縮能調整を組み込んだ心臓機能管理 Download PDFInfo
- Publication number
- JP5525532B2 JP5525532B2 JP2011527815A JP2011527815A JP5525532B2 JP 5525532 B2 JP5525532 B2 JP 5525532B2 JP 2011527815 A JP2011527815 A JP 2011527815A JP 2011527815 A JP2011527815 A JP 2011527815A JP 5525532 B2 JP5525532 B2 JP 5525532B2
- Authority
- JP
- Japan
- Prior art keywords
- ccm
- therapy
- circuit
- adverse event
- neural stimulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000002107 myocardial effect Effects 0.000 title claims description 16
- 230000004217 heart function Effects 0.000 title description 16
- 238000002560 therapeutic procedure Methods 0.000 claims description 522
- 230000000638 stimulation Effects 0.000 claims description 191
- 230000001537 neural effect Effects 0.000 claims description 119
- 238000001514 detection method Methods 0.000 claims description 101
- 230000000747 cardiac effect Effects 0.000 claims description 99
- 210000002216 heart Anatomy 0.000 claims description 86
- 230000006870 function Effects 0.000 claims description 50
- 230000004044 response Effects 0.000 claims description 46
- 206010019280 Heart failures Diseases 0.000 claims description 40
- 230000036279 refractory period Effects 0.000 claims description 40
- 238000007726 management method Methods 0.000 claims description 31
- 230000033764 rhythmic process Effects 0.000 claims description 26
- 230000005713 exacerbation Effects 0.000 claims description 25
- 230000037081 physical activity Effects 0.000 claims description 24
- 206010003119 arrhythmia Diseases 0.000 claims description 17
- 238000005259 measurement Methods 0.000 claims description 17
- 230000000004 hemodynamic effect Effects 0.000 claims description 15
- 230000003907 kidney function Effects 0.000 claims description 15
- 230000004936 stimulating effect Effects 0.000 claims description 11
- 230000002411 adverse Effects 0.000 claims description 9
- 230000006872 improvement Effects 0.000 claims description 9
- 208000000059 Dyspnea Diseases 0.000 claims description 8
- 206010013975 Dyspnoeas Diseases 0.000 claims description 8
- 230000029058 respiratory gaseous exchange Effects 0.000 claims description 7
- 208000010125 myocardial infarction Diseases 0.000 claims description 6
- 208000031225 myocardial ischemia Diseases 0.000 claims description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
- 208000035475 disorder Diseases 0.000 claims description 4
- 238000002595 magnetic resonance imaging Methods 0.000 claims 1
- 238000000034 method Methods 0.000 description 241
- 238000009125 cardiac resynchronization therapy Methods 0.000 description 89
- 239000003990 capacitor Substances 0.000 description 85
- 208000001871 Tachycardia Diseases 0.000 description 79
- 230000008569 process Effects 0.000 description 70
- 230000002861 ventricular Effects 0.000 description 69
- 206010049447 Tachyarrhythmia Diseases 0.000 description 68
- 230000008878 coupling Effects 0.000 description 59
- 238000010168 coupling process Methods 0.000 description 59
- 238000005859 coupling reaction Methods 0.000 description 59
- 230000000763 evoking effect Effects 0.000 description 51
- 238000012360 testing method Methods 0.000 description 48
- 230000001746 atrial effect Effects 0.000 description 37
- 230000035939 shock Effects 0.000 description 30
- 230000001965 increasing effect Effects 0.000 description 27
- 210000005241 right ventricle Anatomy 0.000 description 27
- 230000008859 change Effects 0.000 description 22
- 210000005242 cardiac chamber Anatomy 0.000 description 19
- 230000010247 heart contraction Effects 0.000 description 19
- 230000008602 contraction Effects 0.000 description 17
- 230000000694 effects Effects 0.000 description 17
- 230000003993 interaction Effects 0.000 description 17
- 230000028161 membrane depolarization Effects 0.000 description 16
- 230000000877 morphologic effect Effects 0.000 description 16
- 238000002633 shock therapy Methods 0.000 description 16
- 206010003658 Atrial Fibrillation Diseases 0.000 description 12
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 12
- 210000005240 left ventricle Anatomy 0.000 description 12
- 230000002503 metabolic effect Effects 0.000 description 12
- 230000007383 nerve stimulation Effects 0.000 description 12
- 230000001734 parasympathetic effect Effects 0.000 description 12
- 230000002829 reductive effect Effects 0.000 description 12
- 230000002889 sympathetic effect Effects 0.000 description 12
- 238000013194 cardioversion Methods 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 230000000977 initiatory effect Effects 0.000 description 10
- 210000001186 vagus nerve Anatomy 0.000 description 10
- 238000004891 communication Methods 0.000 description 9
- 238000012544 monitoring process Methods 0.000 description 9
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 8
- 230000008901 benefit Effects 0.000 description 8
- 230000036772 blood pressure Effects 0.000 description 8
- 208000006218 bradycardia Diseases 0.000 description 8
- 230000036471 bradycardia Effects 0.000 description 8
- 239000011575 calcium Substances 0.000 description 8
- 229910052791 calcium Inorganic materials 0.000 description 8
- 230000007423 decrease Effects 0.000 description 8
- 230000003247 decreasing effect Effects 0.000 description 8
- 238000000718 qrs complex Methods 0.000 description 8
- 230000006793 arrhythmia Effects 0.000 description 7
- 210000005245 right atrium Anatomy 0.000 description 7
- 206010047302 ventricular tachycardia Diseases 0.000 description 7
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 6
- 230000000875 corresponding effect Effects 0.000 description 6
- 229940109239 creatinine Drugs 0.000 description 6
- 239000003792 electrolyte Substances 0.000 description 6
- 210000005036 nerve Anatomy 0.000 description 6
- 239000011591 potassium Substances 0.000 description 6
- 229910052700 potassium Inorganic materials 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 206010065342 Supraventricular tachyarrhythmia Diseases 0.000 description 5
- 206010065341 Ventricular tachyarrhythmia Diseases 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 230000001684 chronic effect Effects 0.000 description 5
- 230000006866 deterioration Effects 0.000 description 5
- 230000024924 glomerular filtration Effects 0.000 description 5
- 238000003384 imaging method Methods 0.000 description 5
- 230000010354 integration Effects 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 230000002195 synergetic effect Effects 0.000 description 5
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 230000004962 physiological condition Effects 0.000 description 4
- 230000000241 respiratory effect Effects 0.000 description 4
- 230000002269 spontaneous effect Effects 0.000 description 4
- 230000001515 vagal effect Effects 0.000 description 4
- 230000036982 action potential Effects 0.000 description 3
- 206010061592 cardiac fibrillation Diseases 0.000 description 3
- 230000002600 fibrillogenic effect Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 238000007914 intraventricular administration Methods 0.000 description 3
- 230000008035 nerve activity Effects 0.000 description 3
- 230000036963 noncompetitive effect Effects 0.000 description 3
- 210000001147 pulmonary artery Anatomy 0.000 description 3
- 230000002336 repolarization Effects 0.000 description 3
- 230000000153 supplemental effect Effects 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 208000033988 Device pacing issue Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010037423 Pulmonary oedema Diseases 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000003042 antagnostic effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000003915 cell function Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 210000002837 heart atrium Anatomy 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 210000000663 muscle cell Anatomy 0.000 description 2
- 230000001536 pro-arrhythmogenic effect Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 208000005333 pulmonary edema Diseases 0.000 description 2
- 230000000541 pulsatile effect Effects 0.000 description 2
- 230000010349 pulsation Effects 0.000 description 2
- 230000004213 regulation of atrial cardiomyocyte membrane depolarization Effects 0.000 description 2
- 230000034225 regulation of ventricular cardiomyocyte membrane depolarization Effects 0.000 description 2
- 238000007634 remodeling Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical compound CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 1
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- IRPVABHDSJVBNZ-RTHVDDQRSA-N 5-[1-(cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(C(F)(F)F)C(N)=NC=C1C1=NN(CC2CC2)C(C2[C@@H]3CN(C[C@@H]32)C2COC2)=C1 IRPVABHDSJVBNZ-RTHVDDQRSA-N 0.000 description 1
- KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- PQSUYGKTWSAVDQ-ZVIOFETBSA-N Aldosterone Chemical compound C([C@@]1([C@@H](C(=O)CO)CC[C@H]1[C@@H]1CC2)C=O)[C@H](O)[C@@H]1[C@]1(C)C2=CC(=O)CC1 PQSUYGKTWSAVDQ-ZVIOFETBSA-N 0.000 description 1
- PQSUYGKTWSAVDQ-UHFFFAOYSA-N Aldosterone Natural products C1CC2C3CCC(C(=O)CO)C3(C=O)CC(O)C2C2(C)C1=CC(=O)CC2 PQSUYGKTWSAVDQ-UHFFFAOYSA-N 0.000 description 1
- 206010003130 Arrhythmia supraventricular Diseases 0.000 description 1
- 206010005746 Blood pressure fluctuation Diseases 0.000 description 1
- 108010074051 C-Reactive Protein Proteins 0.000 description 1
- 102100032752 C-reactive protein Human genes 0.000 description 1
- 206010014020 Ear pain Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010021079 Hypopnoea Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- 108020001621 Natriuretic Peptide Proteins 0.000 description 1
- 102000004571 Natriuretic peptide Human genes 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 206010040741 Sinus bradycardia Diseases 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 208000009729 Ventricular Premature Complexes Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229960002478 aldosterone Drugs 0.000 description 1
- 208000008784 apnea Diseases 0.000 description 1
- 230000002763 arrhythmic effect Effects 0.000 description 1
- 230000003126 arrythmogenic effect Effects 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 206010003668 atrial tachycardia Diseases 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000000059 bradycardiac effect Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229940030602 cardiac therapy drug Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 210000003748 coronary sinus Anatomy 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 239000000692 natriuretic peptide Substances 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 230000003094 perturbing effect Effects 0.000 description 1
- 230000037074 physically active Effects 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000017105 transposition Effects 0.000 description 1
- 238000009966 trimming Methods 0.000 description 1
- 102000003390 tumor necrosis factor Human genes 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/3627—Heart stimulators for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/36182—Direction of the electrical field, e.g. with sleeve around stimulating electrode
- A61N1/36185—Selection of the electrode configuration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
- A61N1/368—Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions
- A61N1/3686—Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions configured for selecting the electrode configuration on a lead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/37—Monitoring; Protecting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36114—Cardiac control, e.g. by vagal stimulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/37—Monitoring; Protecting
- A61N1/3706—Pacemaker parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/37—Monitoring; Protecting
- A61N1/3706—Pacemaker parameters
- A61N1/3708—Pacemaker parameters for power depletion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/37—Monitoring; Protecting
- A61N1/371—Capture, i.e. successful stimulation
- A61N1/3712—Auto-capture, i.e. automatic adjustment of the stimulation threshold
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/3956—Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
- A61N1/3962—Implantable devices for applying electric shocks to the heart, e.g. for cardioversion in combination with another heart therapy
- A61N1/39622—Pacing therapy
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Radiology & Medical Imaging (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Electrotherapy Devices (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9742008P | 2008-09-16 | 2008-09-16 | |
| US61/097,420 | 2008-09-16 | ||
| PCT/US2009/005165 WO2010033190A2 (en) | 2008-09-16 | 2009-09-16 | Cardiac function management integrating cardiac contractility modulation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012502729A JP2012502729A (ja) | 2012-02-02 |
| JP2012502729A5 JP2012502729A5 (enExample) | 2012-11-01 |
| JP5525532B2 true JP5525532B2 (ja) | 2014-06-18 |
Family
ID=41226893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011527815A Expired - Fee Related JP5525532B2 (ja) | 2008-09-16 | 2009-09-16 | 心筋収縮能調整を組み込んだ心臓機能管理 |
Country Status (4)
| Country | Link |
|---|---|
| US (4) | US8634910B2 (enExample) |
| EP (1) | EP2358431A2 (enExample) |
| JP (1) | JP5525532B2 (enExample) |
| WO (1) | WO2010033190A2 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8634910B2 (en) * | 2008-09-16 | 2014-01-21 | Cardiac Pacemakers, Inc. | Cardiac function management integrating cardiac contractility modulation |
| US20100198295A1 (en) * | 2009-01-30 | 2010-08-05 | Medtronic, Inc. | Performing extended capture detection test after detecting inadequate capture |
| EP2421605B1 (en) * | 2009-04-23 | 2017-07-12 | Impulse Dynamics NV | Implantable lead connector |
| US8571656B2 (en) * | 2009-12-15 | 2013-10-29 | Cardiac Pacemakers, Inc. | Ventricular pacing to augment atrial natriuretic hormone production |
| JP5525655B2 (ja) | 2010-06-29 | 2014-06-18 | カーディアック ペースメイカーズ， インコーポレイテッド | ケーブルマイクロホン効果によるリード線の動き検知 |
| EP2540342A1 (de) | 2011-06-28 | 2013-01-02 | BIOTRONIK SE & Co. KG | Herzstimulator zur Abgabe einer kardialen Kontraktilitätsmodulationstherapie |
| EP2540341B1 (de) | 2011-06-28 | 2016-07-27 | BIOTRONIK SE & Co. KG | Herzstimulator zur Abgabe einer kardialen Konktraktilitätsmodulationstherapie |
| US8821705B2 (en) * | 2011-11-25 | 2014-09-02 | Tecan Trading Ag | Digital microfluidics system with disposable cartridges |
| EP2628503B1 (de) | 2012-02-16 | 2016-02-24 | BIOTRONIK SE & Co. KG | Herzstimulator für eine kardiale Kontraktilitätsmodulation |
| US20150111918A1 (en) | 2012-03-08 | 2015-04-23 | Medtronic Ardian Luxembourg S.a.r.l | Immune system neuromodulation and associated systems and methods |
| US8504161B1 (en) * | 2012-08-07 | 2013-08-06 | Medtronic, Inc. | Modulate vagal signals to reduce inflammation |
| EP2885050A1 (en) * | 2012-08-16 | 2015-06-24 | Cardiac Pacemakers, Inc. | Therapy delivery architecture for implantable medical device |
| US9446247B2 (en) * | 2013-05-21 | 2016-09-20 | Mr3 Medical, Llc | System and method for stimulating the heart using sub-threshold biphasic stimulation |
| US20190069949A1 (en) | 2014-12-03 | 2019-03-07 | Metavention, Inc. | Systems and methods for modulatng nerves or other tissue |
| JP2016158914A (ja) * | 2015-03-03 | 2016-09-05 | サンリツオートメイション株式会社 | 突然死回避システム |
| EP3351289A1 (en) * | 2017-01-24 | 2018-07-25 | BIOTRONIK SE & Co. KG | System and method for measuring effectiveness of autonomic neurostimulation |
| US10625079B2 (en) * | 2017-11-03 | 2020-04-21 | Pacesetter, Inc. | Method and system for managing residual charge for multi-point pacing therapy |
| US11951319B2 (en) * | 2018-08-07 | 2024-04-09 | Pacesetter, Inc. | Systems and methods for applying anti-tachycardia pacing using subcutaneous implantable cardioverter-defibrillators |
| JP2022553322A (ja) * | 2019-10-23 | 2022-12-22 | インパルス ダイナミクス エヌヴイ | 心房性不整脈患者のための心臓収縮性調節 |
| US20220387790A1 (en) * | 2019-10-23 | 2022-12-08 | Impulse Dynamics Nv | Increasing peak vo2 in patients with hf using cardiac contractility modulation stimulation |
| EP3858429B1 (en) * | 2020-02-03 | 2023-06-14 | BIOTRONIK SE & Co. KG | Implantable medical device for stimulating a human or animal heart |
| WO2021260620A1 (en) * | 2020-06-25 | 2021-12-30 | Impulse Dynamics Nv | Treating crt non-responders using cardiac contractility modulation therapy |
| WO2022123547A1 (en) * | 2020-12-13 | 2022-06-16 | Impulse Dynamics Nv | Combined implantable pulse generator device |
| US20230001204A1 (en) * | 2021-07-02 | 2023-01-05 | Impulse Dynamics Nv | Means and methods for using non-excitatory electrical heart failure therapy as a therapy for heart failure with preserved ejection fraction |
| CN114870258A (zh) * | 2022-04-12 | 2022-08-09 | 苏州维伟思医疗科技有限公司 | 植入式心脏医疗设备、医疗系统及医疗设备控制方法 |
| WO2025027523A1 (en) * | 2023-08-01 | 2025-02-06 | Medtronic, Inc. | Optimizing neuromodulation therapies according to cardiac refractory periods |
| WO2025126057A1 (en) * | 2023-12-14 | 2025-06-19 | Impulse Dynamics Nv | His bundle pacing and cardiac contractility modulation treatment |
Family Cites Families (60)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4590941A (en) | 1981-03-02 | 1986-05-27 | Cordis Corporation | Cardiac pacer with improved battery system, output circuitry, and emergency operation |
| US5086774A (en) * | 1990-04-02 | 1992-02-11 | Siemens-Pacesetter, Inc. | System and method for automatically compensating for latency conduction time in a programmable pacemaker |
| US5184615A (en) | 1991-03-08 | 1993-02-09 | Telectronics Pacing Systems, Inc. | Apparatus and method for detecting abnormal cardiac rhythms using evoked potential measurements in an arrhythmia control system |
| AU724404B2 (en) | 1996-01-08 | 2000-09-21 | Impulse Dynamics N.V. | Electrical muscle controller |
| US8825152B2 (en) | 1996-01-08 | 2014-09-02 | Impulse Dynamics, N.V. | Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue |
| US7167748B2 (en) | 1996-01-08 | 2007-01-23 | Impulse Dynamics Nv | Electrical muscle controller |
| US6463324B1 (en) | 1996-09-16 | 2002-10-08 | Impulse Dynamics N. V. | Cardiac output enhanced pacemaker |
| ZA976113B (en) | 1996-09-16 | 1998-03-19 | New Technologies Sa Ysy Ltd | Drug-device combination for controlling the contractility of muscles. |
| US6725093B1 (en) | 1998-11-06 | 2004-04-20 | Impulse Dynamics N.V. | Regulation of excitable tissue control of the heart based on physiological input |
| AU1072100A (en) | 1998-11-06 | 2000-05-29 | Impulse Dynamics N.V. | Trigger-based regulation of excitable tissue control in the heart |
| US6675043B1 (en) | 1998-11-06 | 2004-01-06 | Impulse Dynamics N.V. | Sensor-based regulation of excitable tissue control of the heart |
| US6292693B1 (en) | 1998-11-06 | 2001-09-18 | Impulse Dynamics N.V. | Contractility enhancement using excitable tissue control and multi-site pacing |
| US6263242B1 (en) | 1999-03-25 | 2001-07-17 | Impulse Dynamics N.V. | Apparatus and method for timing the delivery of non-excitatory ETC signals to a heart |
| US6370430B1 (en) | 1999-03-25 | 2002-04-09 | Impulse Dynamics N.V. | Apparatus and method for controlling the delivery of non-excitatory cardiac contractility modulating signals to a heart |
| US6233487B1 (en) | 1999-06-08 | 2001-05-15 | Impulse Dynamics N.V. | Apparatus and method for setting the parameters of an alert window used for timing the delivery of ETC signals to a heart under varying cardiac conditions |
| US6223072B1 (en) | 1999-06-08 | 2001-04-24 | Impulse Dynamics N.V. | Apparatus and method for collecting data useful for determining the parameters of an alert window for timing delivery of ETC signals to a heart under varying cardiac conditions |
| US6360126B1 (en) * | 1999-08-20 | 2002-03-19 | Impulse Dynamics N.V. | Apparatus and method for controlling the delivery of contractility modulating non-excitatory signals to the heart |
| AU1049901A (en) | 1999-10-25 | 2001-05-08 | Impulse Dynamics N.V. | Cardiac contractility modulation device having anti-arrhythmic capabilities and a method of operating thereof |
| US6993385B1 (en) | 1999-10-25 | 2006-01-31 | Impulse Dynamics N.V. | Cardiac contractility modulation device having anti-arrhythmic capabilities and a method of operating thereof |
| US7027863B1 (en) | 1999-10-25 | 2006-04-11 | Impulse Dynamics N.V. | Device for cardiac therapy |
| US6480737B1 (en) | 1999-12-29 | 2002-11-12 | Impulse Dynamics Nv | Field delivery safety system using detection of atypical ECG |
| EP1267992A4 (en) | 2000-04-06 | 2008-12-10 | Impulse Dynamics Nv | CONTRACTION IMPROVEMENT USING CONTROLLABLE TISSUE AND STIMULATION IN MULTIPLE SITES |
| US6640135B1 (en) | 2000-04-06 | 2003-10-28 | Cardiac Pacemakers, Inc. | Apparatus and method for spatially and temporally distributing cardiac electrical stimulation |
| AU5504301A (en) | 2000-05-04 | 2001-11-12 | Impulse Dynamics N.V. | Signal delivery through the right ventricular septum |
| US6704598B2 (en) | 2001-05-23 | 2004-03-09 | Cardiac Pacemakers, Inc. | Cardiac rhythm management system selecting between multiple same-chamber electrodes for delivering cardiac therapy |
| US7191000B2 (en) | 2001-07-31 | 2007-03-13 | Cardiac Pacemakers, Inc. | Cardiac rhythm management system for edema |
| US7228175B2 (en) | 2002-05-15 | 2007-06-05 | Cardiac Pacemakers, Inc. | Cardiac rhythm management systems and methods using acoustic contractility indicator |
| US7477932B2 (en) | 2003-05-28 | 2009-01-13 | Cardiac Pacemakers, Inc. | Cardiac waveform template creation, maintenance and use |
| US7292888B2 (en) | 2003-08-11 | 2007-11-06 | Medtronic, Inc. | Cardiac stimulation during a refractory period |
| US7233824B2 (en) | 2003-10-07 | 2007-06-19 | Medtronic, Inc. | Secure and efficacious therapy delivery for an extra-systolic stimulation pacing engine |
| US7130687B2 (en) | 2003-10-24 | 2006-10-31 | Medtronic, Inc | Implantable medical device and method for delivering therapy for sleep-disordered breathing |
| US20070191901A1 (en) | 2004-06-04 | 2007-08-16 | Pacesetter, Inc. | Quantifying systolic and diastolic cardiac performance from dynamic impedance waveforms |
| US7764995B2 (en) | 2004-06-07 | 2010-07-27 | Cardiac Pacemakers, Inc. | Method and apparatus to modulate cellular regeneration post myocardial infarct |
| US7765001B2 (en) | 2005-08-31 | 2010-07-27 | Ebr Systems, Inc. | Methods and systems for heart failure prevention and treatments using ultrasound and leadless implantable devices |
| US7828711B2 (en) * | 2004-08-16 | 2010-11-09 | Cardiac Pacemakers, Inc. | Method and apparatus for modulating cellular growth and regeneration using ventricular assist device |
| US20060178586A1 (en) | 2005-02-07 | 2006-08-10 | Dobak John D Iii | Devices and methods for accelerometer-based characterization of cardiac function and identification of LV target pacing zones |
| US7289850B2 (en) | 2005-04-28 | 2007-10-30 | Medtronics, Inc. | System for enhanced cardiac function with combined PESP/NES |
| US7561923B2 (en) | 2005-05-09 | 2009-07-14 | Cardiac Pacemakers, Inc. | Method and apparatus for controlling autonomic balance using neural stimulation |
| US20070060962A1 (en) | 2005-07-26 | 2007-03-15 | Carlo Pappone | Apparatus and methods for cardiac resynchronization therapy and cardiac contractility modulation |
| WO2007029254A2 (en) | 2005-09-06 | 2007-03-15 | Impulse Dynamics N.V. | Apparatus and method for delivering electrical signals to a heart |
| US7616990B2 (en) | 2005-10-24 | 2009-11-10 | Cardiac Pacemakers, Inc. | Implantable and rechargeable neural stimulator |
| WO2007091244A1 (en) | 2006-02-07 | 2007-08-16 | Impulse Dynamics Nv | Assessing cardiac activity |
| US7509167B2 (en) * | 2006-02-16 | 2009-03-24 | Cardiac Pacemakers, Inc. | MRI detector for implantable medical device |
| DE102006015013B4 (de) | 2006-03-31 | 2010-06-02 | Siemens Ag | Implantierbarer Herzschrittmacher |
| US8046064B2 (en) | 2006-04-24 | 2011-10-25 | Medtronic, Inc. | Method of delivering PESP/ICC as well as adjusting the refractory period of the heart |
| US8126554B2 (en) | 2006-05-17 | 2012-02-28 | Cardiac Pacemakers, Inc. | Implantable medical device with chemical sensor and related methods |
| US9295845B2 (en) | 2006-06-29 | 2016-03-29 | Cardiac Pacemakers, Inc. | Post-MI pacing with autocapture function |
| US8226570B2 (en) * | 2006-08-08 | 2012-07-24 | Cardiac Pacemakers, Inc. | Respiration monitoring for heart failure using implantable device |
| US20080046037A1 (en) * | 2006-08-18 | 2008-02-21 | Haubrich Gregory J | Wireless Communication Network for an Implantable Medical Device System |
| US7797041B2 (en) * | 2006-10-11 | 2010-09-14 | Cardiac Pacemakers, Inc. | Transcutaneous neurostimulator for modulating cardiovascular function |
| US20080132966A1 (en) | 2006-12-05 | 2008-06-05 | G&L Consulting, Llc | Stimulation of coronary artery baroreceptors |
| US8523771B2 (en) | 2007-02-12 | 2013-09-03 | Cardiac Pacemakers, Inc. | Cardiovascular pressure annotations and logbook |
| US7711420B2 (en) | 2007-03-19 | 2010-05-04 | Cardiac Pacemakers, Inc. | Closed-loop control of cardioprotective pre-excitation pacing |
| US7778707B2 (en) | 2007-03-21 | 2010-08-17 | Cardiac Pacemakers, Inc. | Method and device for myocardial stress redistribution |
| US7856266B1 (en) | 2007-05-31 | 2010-12-21 | Pacesetter, Inc. | Implantable cardiac stimulation device providing reduced defibrillation thresholds and method |
| US7962212B2 (en) | 2007-08-02 | 2011-06-14 | Cameron Health, Inc. | Multiple battery configurations in an implantable medical device |
| US8131363B2 (en) * | 2007-09-25 | 2012-03-06 | Cardiac Pacemakers, Inc. | Closed-loop control of intermittent excitatory cardiac stimulation for therapeutic effect |
| EP2231271B1 (en) * | 2007-12-12 | 2016-06-22 | Cardiac Pacemakers, Inc. | Implantable medical device with hall sensor |
| US7970463B2 (en) * | 2007-12-20 | 2011-06-28 | Cardiac Pacemakers, Inc. | Anti-tachyarrhythmia system with unified atrial tachyarrhythmia rate threshold |
| US8634910B2 (en) * | 2008-09-16 | 2014-01-21 | Cardiac Pacemakers, Inc. | Cardiac function management integrating cardiac contractility modulation |
-
2009
- 2009-09-16 US US12/561,124 patent/US8634910B2/en not_active Expired - Fee Related
- 2009-09-16 EP EP09789318A patent/EP2358431A2/en not_active Withdrawn
- 2009-09-16 JP JP2011527815A patent/JP5525532B2/ja not_active Expired - Fee Related
- 2009-09-16 WO PCT/US2009/005165 patent/WO2010033190A2/en not_active Ceased
- 2009-09-16 US US12/561,143 patent/US8718761B2/en not_active Expired - Fee Related
- 2009-09-16 US US12/561,137 patent/US8718764B2/en not_active Expired - Fee Related
- 2009-09-16 US US12/561,128 patent/US8712520B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2012502729A (ja) | 2012-02-02 |
| US8718764B2 (en) | 2014-05-06 |
| US20100069984A1 (en) | 2010-03-18 |
| US8712520B2 (en) | 2014-04-29 |
| WO2010033190A2 (en) | 2010-03-25 |
| US20100069980A1 (en) | 2010-03-18 |
| US20100069985A1 (en) | 2010-03-18 |
| WO2010033190A3 (en) | 2011-03-03 |
| US8634910B2 (en) | 2014-01-21 |
| US8718761B2 (en) | 2014-05-06 |
| US20100069977A1 (en) | 2010-03-18 |
| EP2358431A2 (en) | 2011-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5525532B2 (ja) | 心筋収縮能調整を組み込んだ心臓機能管理 | |
| US20220161035A1 (en) | Efficient delivery of multi-site pacing | |
| JP6412250B2 (ja) | マルチプル通信モードを備えた医療機器システム | |
| US8617082B2 (en) | Heart sounds-based pacing optimization | |
| US8781582B2 (en) | Vagal stimulation | |
| US7123961B1 (en) | Stimulation of autonomic nerves | |
| US9101772B2 (en) | Secure and efficacious therapy delivery for a pacing engine | |
| JP5184525B2 (ja) | 心臓ペーシング治療供給システム | |
| US20180078773A1 (en) | Multi-device cardiac resynchronization therapy with mode switching timing reference | |
| US8718763B2 (en) | Vagal stimulation | |
| JP5153879B2 (ja) | 治療効果のための間欠的興奮性心刺激の閉ループ制御 | |
| US20140316486A1 (en) | Vagal stimulation | |
| US20120185009A1 (en) | Vagal stimulation | |
| US8150512B2 (en) | Use of impedance to assess electrode locations | |
| US20190381323A1 (en) | Delivery of cardiac pacing therapy for cardiac remodeling | |
| US8175706B2 (en) | Overlapping pacing and tachyarrhythmia detection zones | |
| JP4988720B2 (ja) | 閾値下の心房ペーシングを識別するための逆行性心房感知 | |
| EP2742972B1 (en) | Capture confirmation for multi-site pacing | |
| JP5174818B2 (ja) | 治療効果のための断続的高エネルギー心臓刺激 | |
| US8903490B2 (en) | Methods and systems for recognizing arrhythmias using neural stimulation | |
| US9314634B2 (en) | Initiation tests and guidelines for implementing cardiac therapy | |
| US9044615B2 (en) | Method and system for validating local capture in multisite pacing delivery |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20120217 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120914 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120914 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20131203 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140226 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140325 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140411 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5525532 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| LAPS | Cancellation because of no payment of annual fees |